CLYM Climb Bio, Inc: Uzoq muddatli qarzning kapitalga koeffitsiyenti

Climb Bio, Inc (CLYM) brendining ramzi va logotipi

Climb Bio Inc (CLYM) murakkab autoimmun patologiyalar uchun dori vositalarini ishlab chiqish maqsadida tadqiqot erkinligi va aksiyalar opsion dasturlari orqali yetakchi olimlarni jalb qilmoqda. 0.00 ko'rsatkichi bilan tavsiflanuvchi narxlar dinamikasi sug'urta to'lovlari uchun B-hujayra terapiyalariga bog'langan foydaga ega bo'lgan kompaniyaning moliyaviy holatini tasdiqlaydi. Biznes organik tadqiqot va ishlanmalarga (R&D) tayanadi va klinik sinovlarning yakuniy bosqichlarini moliyalashtirish uchun yirik hamkor qidirmoqda.

CLYM - Climb Bio Inc. Uzoq muddatli qarzning o'z kapitaliga nisbati 04.10.2024 - 28.10.2026 oraligʻida

Climb Bio Inc (CLYM) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
Kotirovkalar grafigi Climb Bio Inc.|CLYM - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Climb Bio Inc.|CLYM - Korxona qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Climb Bio|CLYM - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati climbbio.com|CLYM - Kompaniyaning jami aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Climb Bio Inc|CLYM - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati climbbio.com|CLYM - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Climb Bio Inc.
Kompaniyaning dastlabki tahlili:CLYM, Climb Bio Inc.
Climb Bio Inc asosiy tovari

Climb Bio Inc (CLYM) kompaniyasining fundamental barqarorligini baholash uchun moliyaviy leveraj darajasini belgilovchi uzoq muddatli qarzdorlikning kapitalga nisbati koeffitsientini tahlil qilish muhimdir. Uzoq muddatli qarzdorlikning kapitalga nisbati tendentsiyasi qarz moliyalashtirish va aksiyadorlik kapitali o'rtasidagi muvozanatni aks ettiradi, bu esa immunoterapiya dori vositalarini ishlab chiqish va sog'liqni saqlash gigantlaridan investitsiyalarni jalb qilish jarayonida defolt xavfini o'sish potentsiali bilan bog'lash imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati argenx N.V.|BioNTech Group (BNTX) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Abivax S.A. (ABVX)|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|protagonist-inc.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunovant (IMVT)|KNSA: Uzoq muddatli qarzning kapitalga koeffitsiyenti|GRFS (Grifols Group) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Adaptive Biotechnologies Inc. (ADPT) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com (AUPH)|BioCryst Pharmaceuticals (BCRX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Vera Therapeutics Inc (VERA)|Uzoq muddatli qarzning kapitalga nisbati DNTH|Pharvaris Pharma - Uzoq muddatli qarzdorlikning kapitalga nisbati|ABCL: Uzoq muddatli qarzning o'z kapitaliga nisbati|TRML: Uzoq muddatli qarzning o'z kapitaliga nisbati|PGEN (Precigen) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|NKTR (Nektar) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati UPB|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc ZBIO|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi immunome.com (IMNM)|GOSS: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati KalVista Pharma KALV|SEPN: Uzoq muddatli qarzning kapitalga nisbati|PVLA: Uzoq muddatli qarzning o'z kapitaliga nisbati|Savara Inc. (SVRA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|rigel.com (RIGL) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ANAB: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati ATXS|Uzoq muddatli qarzning o'z kapitaliga nisbati ENGN (enGene Bio)|Uzoq muddatli qarzning o'z kapitaliga nisbati rapt.com (RAPT)|Uzoq muddatli qarzning kapitalga nisbati Aerovate Therapeutics JBIO|ACRS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Kyverna Therapeutics, Inc. (KYTX)|TLSA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Cabaletta Bio, Inc (CABA) - Uzoq muddatli qarzning kapitalga nisbati|Ventyx Biosciences, Inc (VTYX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|THTX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati AVTX|Eledon Pharmaceuticals, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Agenus, Inc. AGEN|Uzoq muddatli qarzning o'z kapitaliga nisbati Zura Bio Limited|Uzoq muddatli qarzning kapitalga koeffitsiyenti aTyr Pharmaceuticals ATYR|Uzoq muddatli qarzning kapitalga nisbati ADAG (Adagene Corp)|IMA: Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati shattucklabs.com|Equillium (EQ) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati CNTB|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunic Inc|Uzoq muddatli qarzning kapitalga nisbati ATRA (Atara Biotherapeutics)|Uzoq muddatli qarzning o'z kapitaliga nisbati IFRX (inflarx.de)|Uzoq muddatli qarzning o'z kapitaliga nisbati X4 Pharmaceuticals, Inc. XFOR|ACET - Uzoq muddatli qarzning o'z kapitaliga nisbati|CELU (Celularity Corp) - Uzoq muddatli qarzning o'z kapitaliga nisbati|INMB: Uzoq muddatli majburiyatlarning kapitalga nisbati|BRNS (Barinthus Biotherapeutics) - Uzoq muddatli qarzning o'z kapitaliga nisbati|KZR (kezarlifesciences.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati SAB Biotherapeutics, Inc. SABS|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati Akari Therapeutics PLC|Enlivex Therapeutics (ENLV) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti q32bio.com (QTTB)|Uzoq muddatli qarzning kapitalga nisbati GOVX (GeoVax Labs, Inc.)|edesabiotech.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati iBio (IBIO)|CARM: Uzoq muddatli qarzning kapitalga koeffitsiyenti|XTLB (XTL Biopharmaceuticals, Ltd.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Bolt Biotherapeutics, Inc. (BOLT) - Uzoq muddatli qarzning o'z kapitaliga nisbati|HCWB (HCW Biologics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Aptevo (APVO)|AIM ImmunoTech (AIM) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti aditxt.com (ADTX)|Uzoq muddatli qarzning kapitalga nisbati GRI|XORTX Corp - Uzoq muddatli qarzdorlikning kapitalga nisbati|HIND: Uzoq muddatli qarzning o'z kapitaliga nisbati|REVB: Uzoq muddatli qarzning o'z kapitaliga nisbati|INDP (Indaptus Therapeutics, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Scinai Immunotherapeutics Ltd|CALI (CalciMedica Inc) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati AFMD|Uzoq muddatli qarzning o'z kapitaliga nisbati Allakos Inc. ALLK|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi hookipapharma.com (HOOK)|IGMS: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati iTeos Therapeutics Inc ITOS|OCEA: Uzoq muddatli qarzning kapitalga nisbati|TCBP: Uzoq muddatli qarzning o'z kapitaliga nisbati|Third Harmonic Bio (THRD) - Uzoq muddatli qarzning o'z kapitaliga nisbati